42959-38-6 Usage
General Description
2-Chloro-5-nitronicotinic acid is a chemical compound with the molecular formula C6H3ClNO4. It is a nitro-substituted derivative of nicotinic acid and is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is a pale yellow crystalline solid that is sparingly soluble in water and has a melting point of 160-165 °C. 2-Chloro-5-nitronicotinic acid is known for its ability to act as a chelating agent and form stable complexes with metal ions, making it useful for a variety of industrial and research applications. It is also used in the production of dyes, pigments, and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 42959-38-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,9,5 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 42959-38:
(7*4)+(6*2)+(5*9)+(4*5)+(3*9)+(2*3)+(1*8)=146
146 % 10 = 6
So 42959-38-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H3ClN2O4/c7-5-4(6(10)11)1-3(2-8-5)9(12)13/h1-2H,(H,10,11)
42959-38-6Relevant articles and documents
METHODS OF TREATING AGITATION
-
, (2019/06/23)
The present disclosure relates generally to the treatment of agitation associated with neurodegenerative disorders.
THE NITROPYRIDINYL ETHYLENEIMINE COMPOUND, THE PHARMACEUTICAL COMPOSITION CONTAINING IT, THE PREPARATION METHOD AND USE THEREOF
-
Page/Page column 10, (2011/10/10)
The present invention discloses a nitropyridinyl ethyleneimine compound as shown in the formula I and a preparation method of the same, as well as use of the compound in manufacture of a prodrug and in manufacture of a drug for treating a tumor.
NOVEL ANXIOLYTIC COMPOUNDS
-
Page/Page column 42-43, (2008/12/05)
The present invention relates to chemical compounds of general formula (I) which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.
